Sarah Woodrick, PA
Medical · South Bend, INNPI 1467909697
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,235 of the $4,712 with a category attached, or 89.9%. It is spread thinly across 25 manufacturers, the largest accounting for just 20.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,590, 3.5 times the $457 reported in 2021.
Across 262 payments — averaging $17.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$979
- Johnson & Johnson$626
- Novartis$415
- Galderma Laboratories, L.p.$385
- UCB, Inc.$333
- Incyte Corporation$321
- plus $2K from 19 others
What the payments were for
- Speaking & faculty fees$190%
- Food & beverage$4,23590%
- Education$45910%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 87 | $979 |
| Johnson & Johnson | 22 | $626 |
| Novartis | 33 | $415 |
| Galderma Laboratories, L.p. | 14 | $385 |
| UCB, Inc. | 15 | $333 |
| Incyte Corporation | 12 | $321 |
| Regeneron Healthcare Solutions, Inc. | 9 | $257 |
| Amgen | 7 | $159 |
| Sun Pharmaceutical Industries Inc. | 6 | $145 |
| E.r. Squibb & Sons, L.L.C. | 7 | $138 |
| LEO Pharma Inc. | 8 | $133 |
| Lilly USA, LLC | 8 | $132 |
| Genentech USA, Inc. | 5 | $121 |
| Mallinckrodt Hospital Products Inc. | 3 | $119 |
| Sanofi | 6 | $110 |
| Arcutis Biotherapeutics, Inc. | 5 | $83 |
| Almirall LLC | 4 | $66 |
| Dermavant Sciences, Inc. | 4 | $56 |
| VYNE Pharmaceuticals Inc. | 1 | $27 |
| Merz Pharmaceuticals, LLC | 1 | $23 |
| Journey Medical Corporation | 1 | $21 |
| Boehringer Ingelheim | 1 | $19 |
| Pfizer | 1 | $15 |
| Organon | 1 | $15 |
| GSK | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEMLUVIO$125
How this compares
$4,712 in reported general payments places this provider in the 85th percentile of 273 medical providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 14 | $52,439 |
| Fluorouracil | 24 | $2,132 |
| Calcipotriene | 17 | $1,904 |
| Ketoconazole | 128 | $1,853 |
| Clobetasol Propionate | 42 | $1,417 |
| Clindamycin Phosphate | 38 | $1,261 |
| Triamcinolone Acetonide | 145 | $1,004 |
| Betamethasone Dipropionate | 19 | $898 |
| Econazole Nitrate | 23 | $663 |
| Ciclopirox | 20 | $644 |
| Metronidazole | 14 | $582 |
| MethotrexateMethotrexate Sodium | 31 | $579 |
| Gentamicin Sulfate | 12 | $385 |
| Mupirocin | 45 | $380 |
| Doxycycline Hyclate | 19 | $341 |
Paid to pharmacies, not to this prescriber.
Other medical in South Bend
- Meggie BeckleyIndianapolis$125K
- Jennifer ConnerIndianapolis$98K
- Brandon BoydCarmel$46K
- Karey DavisNew Castle$45K
- Sheryl NewCarmel$39K
- Lindsey GradyValparaiso$39K
- Jennifer IrwinIndianapolis$34K
- Dennae DaltonZionsville$33K
- Jenifer FortneyFort Wayne$26K
- Jordan Stemer-MirandaCrown Point$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.